On the Quest of Risk Stratification in HER2-Positive Breast Cancer

J Natl Cancer Inst. 2022 Mar 8;114(3):345-346. doi: 10.1093/jnci/djab061.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Biomarkers, Tumor / genetics
  • Breast Neoplasms* / genetics
  • Female
  • Humans
  • Receptor, ErbB-2
  • Risk Assessment

Substances

  • Biomarkers, Tumor
  • Receptor, ErbB-2